Original Research
Accepted on 21 Apr 2025
Safety and tolerability of the treatment with a bevacizumab biosimilar (Effivia ® ) in adult Mexican patients with cancer: a multicenter, observational, prospective clinical study
in Anti-Cancer Drugs
- 218 views